カテゴリー： 世界, 医療/バイオ, IMARC

世界の医薬品連続製造市場予測2023年-2028年

【英語タイトル】Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料（IMARC23NOV232）・商品コード：IMARC23NOV232
・発行会社（調査会社）：IMARC
・発行日：2023年10月
・ページ数：148
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

市場概要世界の医薬品連続製造市場規模は2022年に12億米ドルに達しました。今後、IMARC Groupは、同市場が2023年から2028年の間に11.6%の成長率（CAGR）を示し、2028年までに23億米ドルに達すると予測しています。

医薬品連続製造とは、最小限の設備投資で様々な新薬やワクチンの品質と一貫性を高める、エンド・ツー・エンドの医薬品製造アプローチを指します。バッチ処理と比較すると、連続的なフローで動作し、規模を拡大しやすく、製造業者により大きな制御と高度な自動化を提供し、物理的な介入を排除します。これとは別に、医薬品の連続製造は、医薬品の調合期間、人為的ミスのリスク、製造手順のモニタリング、規制ガイドラインとの調和を図るための製品質の向上を最小限に抑えるのに役立ちます。その結果、この技術は製薬会社や製造受託機関（CMO）によって、原薬（API）や医薬品の開発に広く利用されています。現在、統合型、半連続型、制御型があります。

医薬品連続製造市場の動向
現在、市場を牽引している主な要因の1つは、様々な有効な生物製剤を低コストで製造するための効率的な医薬品製造システムに対する需要が増加していることです。この背景には、薬剤不足の深刻化や、慢性疾患の世界的な流行があります。さらに、特にコロナウイルス病（COVID-19）のパンデミック発生時の健康懸念の高まりが、製薬会社に新規ワクチンを製造するための連続製造技術の使用を促し、これがもう一つの成長促進要因として作用しています。これに伴い、医薬品製造手法の急速な自動化や人工知能（AI）ソリューションの大規模な統合など、大幅な技術進歩が市場の成長に寄与しています。その他にも、製薬部門の大幅な改善、研究開発（R&D）活動の継続、食品医薬品局（FDA）承認医薬品の入手可能性に関する意識の高まりなどが、市場に明るい見通しをもたらしています。

主な市場セグメンテーション
IMARC Groupは、2023年から2028年までの世界、地域、国レベルでの予測とともに、市場レポートの各サブセグメントにおける主要動向の分析を提供しています。当レポートでは、治療薬のタイプ、製剤、用途、エンドユーザーに基づいて市場を分類しています。

治療薬のタイプ別内訳
大型分子
低分子

剤形別内訳
固形製剤
液体・半固体製剤

用途別内訳
最終製剤製造
原薬製造

エンドユーザー別内訳
製薬会社
製造受託機関
その他

地域別内訳
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争状況
業界の競争環境は、Baker Perkins、Coperion GmbH (Hillenbrand Inc.)、Eli Lilly and Company、GEA Group Aktiengesellschaft、Glatt GmbH、Korsch AG、Novartis AG、Siemens、SK biotek、Thermo Fisher Scientific Inc.、Viatris Inc.などの主要企業のプロフィールとともに調査されています。

本レポートで扱う主な質問
1. 世界の医薬品連続製造市場の規模は？
2. 2023-2028年の世界の医薬品連続製造市場の予想成長率は？
3. 医薬品連続製造の世界市場を牽引する主要因は？
4. 医薬品連続製造の世界市場におけるCOVID-19の影響は？
5. 世界の医薬品連続製造市場の治療薬タイプ別内訳は？
6. 医薬品連続製造の世界市場における剤形別内訳は？
7. 医薬品連続製造の世界市場の用途別内訳は？
8. 医薬品連続製造の世界市場のエンドユーザー別内訳は？
9. 医薬品連続製造の世界市場における主要地域は？
10. 医薬品連続製造の世界市場における主要プレイヤー/企業は？

1 序論
2 範囲・方法
3 エグゼクティブサマリー
4 イントロダクション
5 医薬品連続製造の世界市場
6 医薬品連続製造の世界市場：治療薬タイプ別分析
7 医薬品連続製造の世界市場：製剤別分析
8 医薬品連続製造の世界市場：用途別分析
9 医薬品連続製造の世界市場：エンドユーザー別分析
10 医薬品連続製造の世界市場：地域別分析
11 SWOT分析
12 バリューチェーン分析
13 ポーターズファイブフォース分析
14 価格分析
15 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmaceutical Continuous Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapeutics Type
6.1 Large Molecules
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Small Molecules
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Formulation
7.1 Solid Formulation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Liquid and Semi-solid Formulation
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Final Drug Product Manufacturing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 API Manufacturing
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Contract Manufacturing Organizations
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Baker Perkins
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Coperion GmbH (Hillenbrand Inc.)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Eli Lilly and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 GEA Group Aktiengesellschaft
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Glatt GmbH
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Korsch AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Novartis AG
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Siemens
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 SK biotek
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Thermo Fisher Scientific Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Viatris Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials

Figure 1: Global: Pharmaceutical Continuous Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Therapeutics Type (in %), 2022
Figure 5: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Formulation (in %), 2022
Figure 6: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Application (in %), 2022
Figure 7: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by End User (in %), 2022
Figure 8: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Region (in %), 2022
Figure 9: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Pharmaceutical Continuous Manufacturing (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Pharmaceutical Continuous Manufacturing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: North America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: North America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: United States: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: United States: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Canada: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Canada: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: China: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: China: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Japan: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Japan: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: India: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: India: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: South Korea: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: South Korea: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Australia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Australia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Indonesia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Indonesia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Europe: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Europe: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Germany: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Germany: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: France: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: France: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: United Kingdom: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: United Kingdom: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Italy: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Italy: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Spain: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Spain: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Russia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Russia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Latin America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Latin America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Brazil: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Brazil: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Mexico: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Mexico: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Breakup by Country (in %), 2022
Figure 75: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Global: Pharmaceutical Continuous Manufacturing Industry: SWOT Analysis
Figure 77: Global: Pharmaceutical Continuous Manufacturing Industry: Value Chain Analysis
Figure 78: Global: Pharmaceutical Continuous Manufacturing Industry: Porter's Five Forces Analysis

★調査レポート[世界の医薬品連続製造市場予測2023年-2028年] (コード：IMARC23NOV232)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医薬品連続製造市場予測2023年-2028年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のモノクローナル抗体市場予測2022年-2028年
  • 世界の血液悪性腫瘍市場予測2023年-2028年
  • 世界のOTC人工涙液市場予測2022年-2028年
  • 世界の臨床栄養市場予測2023年-2028年
  • 世界の生物製剤市場予測2023年-2028年
  • 世界の血液浄化装置市場予測2023年-2028年
  • 世界の消化管治療薬市場予測2023年-2028年
  • 世界の早期毒性試験市場予測2023年-2028年
  • 世界の高脂血症治療薬市場予測2023年-2028年
  • 世界のスタチン市場予測2023年-2028年

    • ◆H&Iグローバルリサーチのお客様（例）◆